Representative before the EPO

Technology company logo thumb
no operation time available
Technology Company

Representative before the EPO

Company dna symphogen a slash s
no operation time available
1 office
active in Legal Services

Henrik Bendiksen has worked on the following 14 EPO patent applications which have been published in the last five years:

EP11733805

METHOD FOR HARVESTING EXPRESSION PRODUCTS

IPC classification:
C12N 7/02, C12N 15/10
Applicant:
Bavarian Nordic A/S
Agent:
Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
GRANT OF PATENT INTENDED
EP12794878

POXVIRUS VECTOR FOR THE EXPRESSION OF BACTERIAL ANTIGENS LINKED TO TETANUS TOXIN FRAGMENT C

IPC classification:
A61K 39/02, C12N 15/86
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
PATENT GRANTED
EP13708667

AGONISTS AND ANTAGONISTS OF TOLL-LIKE RECEPTOR (TLR) 13

IPC classification:
A61K 31/7088, A61P 31/04, A61P 37/02, C12N 15/117
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
GRANT OF PATENT INTENDED
EP13730812

POXVIRAL VECTORS FOR LOW ANTIBODY RESPONSE AFTER A FIRST PRIMING IMMUNIZATION

IPC classification:
C12N 15/86
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
EXAMINATION IN PROGRESS
EP13717721

RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA) RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE

IPC classification:
A61K 39/155, C12Q 1/68
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
EXAMINATION REQUESTED
EP13717720

METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES

IPC classification:
A61K 39/00, A61K 39/12
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
GRANT OF PATENT INTENDED
EP13783852

PR13.5 PROMOTER FOR ROBUST T-CELL AND ANTIBODY RESPONSES

IPC classification:
A61K 39/00, C12N 15/863
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
GRANT OF PATENT INTENDED
EP13154196

Methods for treating cancer with MVA

IPC classification:
A61K 39/00, A61K 39/285, A61P 35/00, C07K 14/47
Applicant:
Bavarian Nordic A/S
Agent:
Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
GRANT OF PATENT INTENDED
EP11723884

NOVEL INTERFERON-ALPHA-PRODUCING BONE MARROW DENDRITIC CELLS

IPC classification:
A61K 39/00, C12N 5/0784
Applicant:
Bavarian Nordic A/S
Agent:
Multiple attorneys, Bavarian Nordic GmbH
Status:
PATENT GRANTED
EP14803277

COMBINATION THERAPY FOR TREATING CANCER WITH A POXVIRUS EXPRESSING A TUMOR ANTIGEN AND AN ANTAGONIST AND/OR AGONIST OF AN IMMUNE CHECKPOINT INHIBITOR

IPC classification:
A61K 39/00
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
EXAMINATION REQUESTED
EP14806215

COMPOSITIONS AND METHODS VECTORS FOR INDUCING AN ENHANCED IMMUNE RESPONSE USING POXVIRUS VECTORS

IPC classification:
C12N 15/86
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
EXAMINATION REQUESTED
EP11701949

VACCINIA VIRUS MUTANTS CONTAINING THE MAJOR GENOMIC DELETIONS OF MVA

IPC classification:
A61K 39/00, C12N 7/00, C12N 7/02, C12N 15/86
Agent:
Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB
Agent:
Multiple attorneys, Bavarian Nordic GmbH
Status:
PATENT GRANTED
EP15724454

COMBINATION THERAPY FOR TREATING CANCER WITH A POXVIRUS EXPRESSING A TUMOR ANTIGEN AND A MONOCLONAL ANTIBODY AGAINST TIM-3

IPC classification:
A61K 39/00, A61K 39/395
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
EXAMINATION REQUESTED
EP15766889

METHODS AND COMPOSITIONS FOR INTRA-NASAL IMMUNIZATION WITH RECOMBINANT MVA ENCODING FLAGELLIN

IPC classification:
A61K 39/00, A61K 39/39, C07K 14/255
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
Request for examination was made

Please Sign in to use this feature